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Summary
Quantum dots (QDs) are luminescent nanoparticles
withuniqueoptical properties that havebeenexploited
for single-cell andwhole-animal imaging.Whencoated
with proteins or biocompatible polymers, QDs are not
deleterious to cells and organisms. However, when
QDs are retained in cells or accumulated in the body
for a long period of time, their coatings may be de-
graded, yielding ‘‘naked’’ QDs. Here, we show that ‘‘na-
ked’’ QDs induce damage to the plasma membrane,
mitochondrion, and nucleus, leading to cell death. Re-
active oxygen species (ROS) are important players in
mediating QD-induced cellular damage. QD-induced
cytotoxicity can be reduced or even eliminatedwithout
covalent binding of protective agents to the QD sur-
face. Results from these studies suggest the critical
role of several subcellular compartments in QD-
induced cytotoxicity and point toward multiple molec-
ular targets in nonclassical apoptosis.
Introduction
Various engineered nanoparticles have become impor-
tant tools in biomedical research, and, among them,
semiconductor nanocrystals called quantum dots
(QDs) show the greatest promise [1, 2]. Their unique op-
tical properties make them advantageous probes for
multicolor and long-term live-cell imaging [3–6]. More-
over, QDs are also excellent candidate agents for in
vivo diagnostic imaging [7–13].
Despite the advantages of QDs over fluorescent dyes,
the toxicity of QDs has not been thoroughly examined.
While mostly neglected, or mainly attributed to the toxic
effects of heavy metals leaching from the nanoparticles,
*Correspondence: dusica.maysinger@mcgill.caQD toxicity may also derive from their intrinsic proper-
ties, such as size and surface chemistry. More impor-
tantly, since QDs are efficient energy donors [14, 15],
they could transfer energy to nearby oxygen molecules,
inducing the generation of reactive oxygen species
(ROS), in turn leading to cell damage or death [16]. In
fact, cadmium selenide (CdSe) QDs have been shown
to generate singlet oxygen in vitro [17]. Singlet oxygen
and/or hydroxyl free radicals photogenerated upon irra-
diation of QDs were also suggested as the most likely
species responsible for the plasmid DNA nicking taking
place immediately upon irradiation of DNA in the pres-
ence of QDs [18]. Generation of free radicals and DNA
damage were observed even without exposure to light,
suggesting that the mechanism of DNA nicking is not
a simple photo-induced free radical process.
Even though some reports show strong evidence for
the survival of cells loaded with QDs for weeks without
alteration in cell growth and division [19], other studies
indicate that high concentrations of QDs (>53 109 QDs/
cell) can impair embryonic development [20]. Polymer-
coated QDs are accumulated in mouse bone marrow,
spleen, and liver for at least 4 months after systemic
administration [21]. QD toxicity can be altered by sur-
face modifications [22, 23], suggesting that reactive
surfaces may play a role in QD-induced cytotoxicity.
Moreover, it has been shown that exposure of the
CdSe core to oxidative environments causes the de-
composition and desorption of Cd2+ ions [22, 24], well
known potent toxins.
In this study, we have explored green, mercaptopro-
pionic acid (MPA)-coated cadmium telluride (CdTe)
QDs synthesized in water. Deprotonated thiols (thio-
lates) are most often used as ligands to stabilize quan-
tum dots in solution, and MPA is among the smallest
ones [25]. It seems that the chain length of the stabilizing
ligand is an important factor controlling the stability of
QDs: longer chains enhance the stability. Aggregation
of QDs in solution takes place when the stabilizing li-
gands are removed from the nanocrystal surface via
protonation [26] or, possibly, photooxidation [25]. We
cannot exclude the possibility that similar processes
may occur during in vitro or in vivo imaging, depending
on the subcellular localization of the QDs and the local
pH and redox environment they encounter. Protein or
polymer QD coatings could be degraded in vivo, yielding
exposed inorganic cores. Such unprotected QDs could
represent a hazard for long-term use of QDs.
As a cellular model, we selected a human breast can-
cer cell line (MCF-7) because they are frequently used in
cancer research and mechanisms involved in cell death
were well studied. In vivo imaging and phototherapy
with QDs have been proposed as highly sensitive, non-
invasive means for early cancer diagnosis and treat-
ment. A prerequisite for such applications is the long-
term safety of QDs.
The aim of this study was to investigate the mecha-
nisms contributing to cellular toxicity of surface-unpro-
tected CdTe QDs in MCF-7 cultures. The investigation
reveals that CdTe QDs induce cell death by nonclassical
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able in live cells.
Results
QDs Trigger Plasma Membrane, Mitochondrial,
and Nuclear Damage in MCF-7 Cells
QDs have been shown to induce a decrease in cell viabil-
ity, which depends on the type of QDs and on the exper-
imental conditions [22, 23, 27, 28]. Subcellular organelles
of dying cells manifest alterations in their morphology
and function. They sense and respond to stressful stim-
uli, leading to adaptation or cell death [29]. To examine
QD-triggered damage of cells on the subcellular level,
we used specific dyes to assess the integrity of plasma
membrane, mitochondrion, and nucleus.
Plasma membrane damage was assessed by using
propidium iodide (PI), a red fluorescent nuclear stain
that cannot enter cells with intact plasma membranes
(Figure 1A). The number of PI-positive cells is increased
after 12 hr upon treatment with QDs (16.4% PI-positive
cells), and it is further increased after 24 hr of treatment
(32% for QD-treated versus 4.3% for controls).
Under stressful conditions, the network of elongated
mitochondria is disintegrated and transformed into ve-
sicular punctiform mitochondria [30]. The effect of QDs
on mitochondrial morphology was analyzed by using
MitoTracker Deep Red 633, which selectively stains
these organelles. In the absence of QDs, mitochondria
are elongated, whereas short, round mitochondria are
aggregated at the perinuclear region after 24 hr in the
presence of QDs (Figure 1B and Figure S1; see the Sup-
plemental Data available with this article online).
Nuclear morphology is an indicator of the health sta-
tus of the cell [31]. Staining the nuclei with Hoechst
33342 revealed shrinkage and deformation of nuclei
with chromatin aggregation, indicating nuclear damage
induced by QD after 24 hr (Figure 1C).
The reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide) to formazan, a mea-
sure of cell metabolic activity, was decreased in
a dose-dependent manner by QD treatment (Figure
1E). Changes in cell number were determined by mea-
suring Hoechst 33342 fluorescence and correlating it
with a calibration curve of a known number of cells. At
concentrations of 1 and 5 mg/ml, QDs did not induce
cell loss (104.8% 6 5.2% and 97.6% 6 4.8% of control
cells, respectively), but, at these concentrations, a de-
crease in cell metabolic activity was detected. However,
at the highest concentration of QDs (10 mg/ml), cell loss
was evident (only 64.3% 6 2.6% cells remained). A de-
crease in the metabolic activity was already observed
4 hr after QD treatment (10 mg/ml, 79.1%6 1.2% of con-
trol cells). At the same time point, cell loss did not yet oc-
cur (98.9% 6 4.4% of control cells).
QD-Induced Cell Death Is Caspase-Independent
Caspase activation is often a critical event in classical
apoptosis aside from the morphological changes during
the apoptosis [32]. MCF-7 cells do not express caspase-
3, main effector caspase, but they do express other
members of the caspase family. It was shown that apo-
ptosis in MCF-7 cells proceeds via sequential activation
of caspase-9, -7, and -6 [33]. So, if QDs induce classicalapoptosis, a caspase inhibitor should be able to prevent
cell death. We therefore used Z-VAD, a broad caspase
inhibitor, to test this hypothesis. Z-VAD (tested in three
different concentrations: 10, 30, and 50 mM) was ineffec-
tive when MCF-7 cells were incubated with QDs (5 or 10
mg/ml, 24 hr). Z-VAD failed to prevent both a decrease in
Figure 1. QDs Induce Damage to Plasma Membrane, Mitochon-
dria, and Nucleus
(A) Confocal micrographs of MCF-7 cells double-stained with
Hoechst 33342 (10 mM) and PI (7.5 mM) 15 hr after QD treatment
(10 mg/ml).
(B) Mitochondria of MCF-7 cells stained with MitoTracker Deep Red
633 (1 mM) 24 hr after QD treatment (5 mg/ml).
(C) Nucleus of MCF-7 cells stained with Hoechst 33342 (10 mM) 24
hr after QD treatment (5 mg/ml).
(D) Quantification of cells with plasma membrane damage (PI pos-
itive) as a percentage of the total number of Hoechst-stained cells
after QD treatment (10 mg/ml).
(E) The metabolic activity of MCF-7 cells exposed to QDs is de-
creased in a concentration-dependent manner (p < 0.001, F3,39 =
121.496). Cells were incubated with QDs for 24 hr.
(F) After 24 hr, cell loss occurs when MCF-7 cells are incubated with
the highest concentration of QDs (10 mg/ml, p < 0.001, F3,35 =
18.602).
For (E) and (F), data represent mean 6 SEM for four and three inde-
pendent experiments, respectively. The scale bar represents
10 mm. *, p < 0.001 as determined with 1-way ANOVA followed
by a post-hoc Dunnett’s test.
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1229metabolic activity and cell number, as assessed by MTT
and Hoechst assay, respectively.
QDs Induce Generation of Reactive Oxygen Species
The generation of excess reactive oxygen species (ROS)
causes the modification and damage of cellular pro-
teins, lipids, and DNA, and it can subsequently lead to
Figure 2. QDs Induce Generation of Reactive Oxygen Species
MCF-7 cells were double stained with DHE (10 mM) and Hoechst
33342 (10 mM) 4 hr after QD treatment (see Experimental Proce-
dures). Confocal micrographs of control cells and QD-treated cells
exposed to both dyes, and cells treated with QDs, but not stained
with DHE. The scale bar represents 10 mm.cell death. To investigate oxidative stress produced by
QDs, we used dihydroethidium (DHE). DHE is oxidized
by ROS to ethidium, which intercalates with cellular
DNA, yielding bright red, fluorescent nuclear staining.
Using confocal microscopy, we observed ROS produc-
tion after 4 hr of QDs exposure in culture medium. Very
little fluorescence from ethidium was detected in control
cells (Figure 2). However, a significant increase in fluo-
rescence was detected in QD-treated cells (Figure 2
and Figure S2).
NAC Prevents QD-Induced Cellular Damage
Our previous studies demonstrated the effectiveness of
antioxidants in preventing the decrease in cell viability
by cysteamine-stabilized QDs [28]. N-acetylcysteine
(NAC), astrong antioxidant containing amercapto group,
provided complete protection against QD-induced
stress. We therefore examined whether the protective
effect of NAC was due to the scavenging of ROS after
QD treatment. Indeed, NAC (4 mM) prevented QD-
induced oxidation of DHE (Figures 3A and 3B and Figure
S2). Upon 1, 4, and 24 hr exposure to QDs, cells treated
with QDs only displayed bright red, fluorescent nuclei,
whereas cells treated with QDs and NAC showed very
weak nuclear staining. NAC preserved the normal mito-
chondrial morphology (Figure 3C) and partially pre-
vented their functional impairment (Figure 3D). However,
NAC was very effective in reducing cell loss (Figure 3E).
QD Treatment Leads to a Reduction of Cytochrome c
Concentration in Mitochondria
The subcellular distribution of certain proteins changes
upon the introduction of stressful stimuli [34]. TheFigure 3. NAC Reduces QD Induction of
ROS and Cellular Damage
(A) Confocal micrographs of DHE-stained
cells treated with QDs only (10 mg/ml) and
QDs in the presence of NAC (4 mM) after 1,
4, and 24 hr.
(B) Semiquantitative analysis of ethidium
fluorescence intensity 4 hr after QD treat-
ment. Relative fluorescence intensity (RFI)
was divided by the number of cells per field.
Results are expressed as an increase of RFI
compared to nontreated control cells (p <
0.05 as determined by a Student’s t test).
(C) Mitochondria stained with MitoTracker
Deep Red 633 (1 mM) 24 hr after QD treatment
(5 mg/ml) in the absence and presence of NAC
(2 mM).
(D) Metabolic activity of cells treated with QD
(10 mg/ml) in the presence and absence of
NAC (4 mM), and respective controls as mea-
sured by an MTT assay. The significant inter-
action between NAC and QDs was deter-
mined by 2-way ANOVA (p < 0.001, F1, 32 =
40.365).
(E) Number of cells 24 hr after QD treatment
(10 mg/ml) in the absence and presence of
NAC (4 mM) as measured by Hoechst assay.
The significant interaction between NAC and
QDs was determined by 2-way ANOVA (p <
0.001, F1, 32 = 78.625).
In (B), (D), and (E), data represent mean 6
SEM for two, four, and three independent ex-
periments, respectively. The scale bar repre-
sents 10 mm.
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that are lethal to the cells once released into cytosol.
One such protein is cytochrome c, which in the cytosol
plays the role of potent amplifier of apoptotic signals
[35]. To investigate the involvement of cytochrome c in
QD-mediated cell death, we isolated enriched mito-
chondrial and cytosolic fractions. Staurosporine (STS),
a potent inducer of cytochrome c release and apoptotic
cell death [36, 37], was used as a positive control for as-
sessing mislocation of cytochrome c. Cytochrome c re-
lease was assessed by Western blotting at two time
points, after 4 hr and after 24 hr. After 4 hr, cytochrome
c release from mitochondria was significantly enhanced
in the cytosol of cells treated with STS (2.5 mM), but not
in the cytosol of cells deprived of serum (S2 cells) or
cells treated with QDs (10 mg/ml) (Figure 4A). However,
after 24 hr, QDs (5 and 10 mg/ml) caused cytochrome c
release from mitochondria (Figure 4B). The intensity of
the cytochrome c immunoreactive band corresponding
to S2 cells was reduced by 20% compared to cells
grown in serum-containing medium (S+), whereas QDs
(5 and 10 mg/ml) led to a greater loss of cytochrome c
(>40%) with concurrent and significant augmentation
in the cytosolic fraction. The mitochondrial loss of cyto-
chrome c was confirmed by using an ELISA assay. The
concentration of cytochrome c in mitochondria after
a 24 hr QD presence in the cell culture was 424 ng/ml,
whereas, in untreated controls, this concentration was
502 ng/ml. However STS (1 mM) induced the most pro-
Figure 4. QD Treatment Leads to a Reduction of Cytochrome c
Concentration in Mitochondria
(A) Immunoblot analysis of cytochrome c, COX-4, and actin in cyto-
solic and mitochondrial-enriched fractions 4 hr after QD treatment
(left). Semiquantitative data from densitometric analysis of cyto-
chrome c in mitochondria and cytosol (right; three independent ex-
periments). [QD] = 10 mg/ml; [STS] = 2.5 mM.
(B) Immunoblot analysis of cytochrome c, COX-4, and actin in mito-
chondrial and cytosolic fractions 24 hr after QD treatment (left), and
semiquantitative data of the immunoreactive bands (right). COX-4
was used as a control for the fractionation efficiency and for equal
loading of proteins in mitochondrial fractions. Actin was used as
a control for equal loading of proteins in cytosolic fractions.nounced decrease in cytochrome c concentration (cyto-
chrome c concentration was only 329 ng/ml).
Discussion
Results from this study show that: (1) unmodified CdTe
QDs induce damage to plasma membrane, mitochon-
drion, and nucleus of MCF-7 cells; (2) QD-induced cellu-
lar damage is mediated by ROS and can be prevented
by treatments with antioxidants; (3) mitochondria re-
lease cytochrome c upon the exposure of MCF-7 cells
to QDs.
In this study, we have employed green mercaptopro-
pionic (MPA)-coated CdTe quantum dots (2r = 2 nm).
The synthesis and properties of QDs employed were
originally described by Gaponik et al. [38]. CdTe nano-
crystals analyzed by X-ray diffraction and transmission
electron microscopy show CdTe cubic crystals, and
the EXAFS studies suggested the chemical formula
(Cd54Te32[SCH2CH2COOH]52)
82 and the formation of
small aggregates (clusters). Light sensitivity (photo-
chemical stability) of CdTe colloids is strongly depen-
dent on the presence of oxygen and free stabilizer mol-
ecules in solution [38]. In oxygen-saturated solutions,
photodegradation of CdTe nanoparticles proceeds
much faster (>20-fold) than under airless conditions.
The photostability of all kinds of thiol-capped CdTe
nanocrystals in the solid state is relatively high and inde-
pendent of the nature of the stabilizer [38]. In this study,
QDs were stabilized by MPA. Loss of MPA could occur
upon exposure of the QD surface to the cellular environ-
ment, possibly leading to oxidation of the inorganic
core, release of Cd2+, and QD aggregation. These phe-
nomena may cause enhanced QD cytotoxicity, as previ-
ously reported [22]. Hoshino et al. reported that QD tox-
icity also depends on the methodology employed to
purify QDs and to remove the excess reactants (such
as MPA) and the by products [23]. In fact, Hoshino
et al. point out that, even after QD purification, toxicity
cannot be fully eliminated. Imaging of unmodified
CdTe QDs is difficult due to their low photolumines-
cence; however, despite this low photoluminescence,
these QDs can be harmful to the cells. Different surface
molecules provide a different degree of protection, and
they act as a barrier to oxygen, protons, or hole traps.
Generally, nanocrystals are less toxic when their sur-
faces are better protected.
The subcellular organelles are points of damage sens-
ing, and, depending on the extent of damage, cells
adapt, repair, or undergo cell death. Our experiments
show that QD treatment leads to plasma membrane
damage, as assessed by PI. The number of PI-stained
cells increases with time, and, upon a 15 hr exposure
to QD, there is maximal damage (Figures 1A and 1D). A
loss of plasma membrane integrity is considered an
early event in necrosis and a late event in apoptosis.
Mitochondrial membrane permeabilization is the point
of convergence of numerous cell death signals and, to-
gether with caspase activation, it is considered to be the
central executioner in apoptosis [29]. Mitochondria are
organelles that are very sensitive to QD-induced stress.
Mitochondrial function is impaired upon cell exposure to
very low QD concentrations (Figure 1E) and soon after
QD treatment. QDs also induced disintegration of the
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chondria in the perinuclear region (Figure 1B and Figure
S1), phenomena characteristic of apoptotic cell death
[30, 39]. Nuclear condensation with DNA fragmentation
is a mark of apoptotic cell death, whereas, in necrosis,
nuclei are swollen. Nuclei in cells with QD-induced dam-
age to the plasma membrane did not show prominent
swelling, but rather shrinkage and deformation (Figure
1C). Due to the lack of caspase-3, the main effector cas-
pase in apoptosis, cell death in MCF-7 sets in without oli-
gonucleosomal DNA fragmentation [40]. We investi-
gated the possible role of other caspases in QD-
induced cell death by pharmacological manipulations.
A broad caspase inhibitor, Z-VAD, failed to prevent
QD-induced cell death, suggesting that the cell death
is caspase-independent. Similarly, QD-induced cell
death in PC12 cells, which do express caspase-3, ap-
pears to be caspase-independent (unpublished data).
Apoptosis-like cell death modes characterized by less
compact/complete chromatin condensation have been
described, and cell death that occurs without caspase
activation falls into this category [31, 41]. Tumor necrosis
factor-induced death of MCF-7 cells induces similar
changes in nuclear morphology [31]. Moreover, there is
necrosis-like cell death that is the result of active cellular
processes, and it can be inhibited by oxygen-radical
scavengers [42]. Cell death in the presence of caspase
inhibition is a subgroup of this necrosis-like cell death
[43]. Taken together, these findings suggest that QD-in-
duced cell death in MCF-7 cultures is not classical ne-
crosis or classical apoptosis.
Reactive oxygen species (ROS) are known to mediate
cell death in a variety of cell types. Green and Howman
reported the production of ROS by CdSe/ZnS QDs in
the presence and absence of light [18]. The mechanism
of ROS formation in the absence of light is not clear.
However, ROS can be formed in an aqueous medium
(e.g., cell culture medium), particularly in the presence
of exogenous oxygen, since the medium is supplied by
CO2/O2. Although we did not intentionally expose cells
to the light or use CdSe/ZnS QDs, a minimal exposure
of CdTe QDs to visible light during solution preparation,
inspection of the cells by an inverted microscope, and
cell treatments could have initiated ROS formation in
aqueous medium kept in a CO2/O2 environment.
Results from our confocal microscopy studies show
evidence of ROS formation upon QD treatment. When
ROS overcome the cellular antioxidant defense system,
cells undergo oxidative stress. Results of this stress in-
clude modification and damage of cellular components,
such as lipids, proteins, and DNA [44, 45]. Oxidation of
unsaturated fatty acids results in the generation of lipid
peroxides that start a chain reaction leading to oxidation
of nearby unsaturated fatty acids that can culminate in
the disruption of the plasma membrane and membranes
of other cellular organelles. QDs produce ROS in vitro
with or without exposure to light [17, 18], and cellular
damages observed in our studies are at least in part
due to QD-generated ROS. Other synthetic nanomateri-
als can also induce oxidative stress; for example, un-
coated fullerenes induce lipid peroxidation and glutathi-
one depletion [46].
We have demonstrated that the QD generation of ROS
is attenuated in the presence of the antioxidant NAC.This antioxidant acts as a direct ROS scavenger and
also, indirectly, as an important cellular antioxidant, by
triggering an increase in the production of glutathione
(GSH) [47]. NAC was shown to maintain mitochondrial
oxidative metabolism [48] and to improve cell survival
in response to various insults [49, 50]. In our study,
NAC abolished ROS-induced oxidation of DHT, as re-
vealed by weak nuclear ethidium staining (Figure 3 and
Figure S2). NAC was able to preserve normal mitochon-
drial morphology after QD treatment. The effect of NAC
on the cell metabolic activity could be ascribed to its
multiple intra- and extracellular effects: (1) NAC can re-
duce the concentration of ROS in the cell culture me-
dium; (2) NAC can induce the synthesis of glutathione,
the most abundant and effective cellular antioxidant;
(3) NAC could improve QD surface passivation, thereby
leading to less damage to the mitochondrial redox sys-
tem. NAC partially prevented functional impairment of
mitochondria and almost completely prevented cell
loss. These findings suggest that mitochondria are early
targets of QD-induced stress and are severely damaged
by QDs. The loss of mitochondrial function could be
a major reason for QD-induced cell death.
The release of cytochrome c from mitochondria is
a central event in apoptotic signaling [51]. A direct role
for ROS in cytochrome c release has been suggested,
and this role involves the oxidation of cardiolipin, a phos-
pholipid that is important for the association of cyto-
chrome c with the inner mitochondrial membrane [52].
In addition, cytochrome c release can be a consequence
of a ROS-induced change in the conformation of ade-
nine nucleotide translocase, a protein involved in mito-
chondrial permeability transition pore formation [53].
Superoxide (O2
2) induces cytochrome c release mainly
due to the voltage-dependent anion channel-selective
permeabilization of the mitochondrial outer membrane
[54]. The onset of cytochrome c release depends on
the duration and intensity of stressful stimuli. It takes
place approximately 4 hr after exposure to strong apo-
ptotic inducers, such as STS [37]. Cytochrome c release
did not occur after a 4 hr QD treatment of MCF-7 cells,
although a significant amount of ROS was detected.
After a 24 hr exposure to QDs, however, the mitochon-
dria of cells exposed to QDs had significantly lost cyto-
chrome c, and prominent immunoreactive bands were
detected in cytosolic fractions. Mitochondrial aggrega-
tion in budding-like structures, known to precede cyto-
chrome c release [39], was also observed in QD-treated
MCF-7 cells. However, the mitochondrial loss of cyto-
chrome c could also be a consequence of oxidative
damage of mitochondrial outer membranes.
We propose the mechanism for QD-induced cell
death that involves QD generation of ROS in the extra-
cellular environment and intracellularly. These ROS
can cause plasma membrane damage and intracellular
organelle damage; mitochondria are the first to be af-
fected, and they appear to be the most sensitive organ-
elles (Figure 5).
Significance
Results from these studies suggest the critical role of
several subcellular compartments in QD-induced cy-
totoxicity and point toward multiple molecular targets
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induced cell death proposed here may take place in
cells treated with modified QDs, once they have lost
their protective surface coating. Our studies show
that ‘‘naked’’ QDs can injure cells, inducing damage
to the plasmamembrane,mitochondrion, and nucleus.
Through electron or energy transfer to the molecular
oxygen, QDs can produce reactive oxygen species
(ROS) [17]. QD-induced ROS formation and the delete-
rious effects associated with it therefore can be pre-
vented either by treatment with antioxidants such as
N-acetylcysteine (NAC) or by surface modifications.
Understanding the molecular mechanisms underlying
QD-induced cell death will allow for the development
of newQDmodifications that could either protect cells
(e.g., if used for real-time imaging) or kill cells more ef-
ficiently (e.g., if used to complement cancer chemo-
therapy).
Experimental Procedures
All reagents were purchased from Sigma-Aldrich (Oakville, ON, Can-
ada) unless indicated otherwise. Green mercaptopropionic acid-
coated CdTe quantum dots (2r = 2 nm) employed in this study
were synthesized as described earlier [38], with a slight modification
already reported by our group [28]. Sodium borohydride (1.60 g, 42.3
mmol) was dissolved in water (40 ml) at 0ºC while stirring under N2.
Tellurium powder (2.56 g, 20.1 mmol) was added portionwise, and
the mixture was stirred at 0ºC under N2 for 8 hr, yielding a purple
NaHTe solution. The reaction mixture was kept at 4ºC in the dark
and was used in the next step. Cadmium perchlorate hydrate (500
ml, 1M aqueous solution) and 3-mercaptopropionic acid (300 ml, 3.9
mmol) were dissolved in water (200 ml). The pH of the solution
was adjusted to 10.5 with a 1 M KOH solution prior to addition of
an aliquot of the NaHTe solution previously prepared (200 ml). The re-
action mixture was heated to reflux for 25 min under N2. The result-
ing QD solution was dialyzed against deionized water for 2 hr and
concentrated by using a rotary evaporator. QDs were collected by
centrifugation and purified by size-selective precipitation.
Cell Culture Conditions, QD, and Drug Treatments
Human breast cancer cells (MCF-7, American Type Culture Collec-
tion [ATCC], Rockville, MD) were maintained as per ATCC recom-
mendations. Cells were cultured (37ºC, 5% CO2) in RPMI 1640 me-
dium containing 10% fetal bovine serum (FBS) (GIBCO-BRL,
Burlington, ON, Canada). RPMI 1640 medium was phenol red-free
and contained 1% penicillin-streptomycin. For spectrofluorometric
and colorimetric assays, cells were cultured in 24-well plates (Sar-
stedt, Montreal, QC, Canada) at a density of 105 cells/cm2.
One hour prior to treatments, medium containing serum was aspi-
rated, and cells were washed with serum-free medium. Fresh serum-
Figure 5. Proposed Mechanism of QD-Induced Toxicityfree medium was added to all wells, except to control cells grown in
10% FBS to account for changes in cell morphology, cell number,
and metabolic activity due to the serum withdrawal.
Cells were treated with QDs (5 or 10 mg/ml) for different time peri-
ods as specified in individual figure legends. QD solutions (5 or 10
mg/ml) were prepared from the stock (2 mg/ml) by dilution in se-
rum-free cell culture medium. Cells were incubated with QDs for
a maximum of 24 hr before biochemical analysis or live-cell imaging.
NAC was dissolved in PBS (400 mM), and was added to the culture
medium 2 hr before QDs. Staurosporine (STS, Sigma) and Z-VAD
(Calbiochem, San Diego, CA) were dissolved in dimethyl sulfoxide
(DMSO). STS (used as a positive control for cytochrome c release
in Western blotting experiments) was diluted to a final concentration
(1 or 2.5 mM) in serum-free medium. Z-VAD was also diluted to a final
concentration (10, 30, or 50 mM) in serum-free medium and was
added to the cells 2 hr before QDs. All treatments were done in trip-
licate or quadruplicate in three or more independent experiments.
MTT Assay
Colorimetric MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazo-
lium bromide, Sigma) assays were performed to assess the meta-
bolic activity of cells treated as described above. After 24 hr of treat-
ment, media were removed and replaced with drug-free, serum-free
media (500 ml/well). A total of 50 ml stock MTT (5 mg/ml) was added to
each well, and cells were then incubated for 1 hr at 37ºC. Media were
removed, cells were lysed, and formazan was dissolved with DMSO.
Absorbance was measured at 595 nm by using a Benchmark micro-
plate reader (Bio-Rad, Mississauga, ON, Canada). All measurements
were done in triplicate in three or more independent experiments.
Hoechst 33342 Assay for Determination of Cell Number
A calibration curve of Hoechst 33342 (Molecular Probes, Eugene,
OR) fluorescence intensity as a function of cell number was created
in order to determine the number of cells present after QD treat-
ments. Cells were counted by using a hemocytometer and were di-
luted in RPMI 1640 medium to obtain samples from 30,000 to
1,000,000 cells. Hoechst 33342 (2 mM) was added to the culture me-
dium (final concentration was 10 mM), and cells were incubated for
30 min at 37ºC. At the end of the incubation period, cells were
spun down, washed with phosphate-buffered saline (PBS), and
lysed with DMSO. Cell lysates were diluted with PBS, and the fluo-
rescence of the samples and respective controls was measured at
lex 350 nm and lem 461 nm by using a Molecular Devices Spectra-
Max Gemini XS microplate spectrofluorometer. The number of cells
present after the treatments with QDs and antioxidants was deter-
mined by measuring Hoechst 33342 fluorescence intensity and ex-
trapolating the cell number by using a calibration curve. After the
treatments, medium containing drugs and QDs was removed, and
cells were washed with serum-free medium. Incubation with
Hoechst 33342, washing steps, and fluorescence measurements
were all performed the same way as for obtaining a calibration curve.
All measurements were done in duplicate in three or more indepen-
dent experiments.
Laser Scanning Confocal Microscopy
Images were acquired with a Zeiss LSM 510 NLO inverted micro-
scope. Cells were grown on 8-well chambers (Lab-Tek, Nalge
Nunc International, Rochester, NY). QDs were added to designated
wells, and the cells were incubated for different time periods.
Plasma membrane damage was investigated by using propidium io-
dide (PI, 7.5 mM, 10 min, Molecular Probes; lex 535 nm, lem 617 nm
[bound to nucleic acids]). The excitation laser and filter used for PI
imaging experiments were HeNe 543 nm and LP 560, respectively.
Mitochondria were stained with MitoTracker Deep Red 633 (1 mM,
1 min, Molecular Probes; lex 644 nm, lem 665 nm) and were imaged
with an HeNe 633 nm excitation laser and an LP 560 filter. Nuclei
were stained with Hoechst 33342 (10 mM, 30 min to 1 hr, Molecular
Probes; lex 350 nm, lem 461 nm) and were analyzed by 2-photon im-
aging (Ti:Sa laser set to pulse at 800 nm and BP 390-465 IR filter). Be-
fore imaging, cells were washed with PBS or with serum-free me-
dium. No background fluorescence of cells was detected under
the settings used. Images were acquired at resolutions of 512 3
512 and 1024 3 1024. In all of the imaging experiments, the number
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1233of averages was four. Scan size was 146.2 mm 3 146.2 mm. Figures
were created with Adobe Photoshop.
ROS Imaging
ROS generation was imaged by using dihydroethidium (Molecular
Probes) and a Zeiss LSM 510 microscope. Cells were cultured for
24 hr on 8-well chamber slides before treatments. After treatments,
cells were washed, and medium was replaced with serum-free me-
dium. Dihydroethidium was dissolved in DMSO (3 mM) and added to
the culture medium at a final concentration of 10 mM, and the cells
were incubated for 30 min at 37ºC. Cells were washed with PBS,
and warmed (37ºC), fresh serum-free medium was added before
cells were examined by laser scanning confocal microscopy. The
oxidation product of DHE is ethidium, whose fluorescence is en-
hancedw10-fold when bound to DNA (lex 518 nm, lem 605 nm). Im-
ages were acquired by using an HeNe 514 nm laser and an LP 560
filter under set conditions (detector gain was kept constant through-
out the experiment). Collected eight-bit images were transferred into
monochrome eight-bit TIF files, and quantification of ethidium fluo-
rescence intensity was performed by using the MCID Elite 7.0 imag-
ing system (Imaging Research, St. Catherine’s, ON, Canada). All of
the results were expressed as relative values to the untreated cells
(controls).
Subcellular Fractionation and Western Blotting
Subcellular fractionation was performed by using the ApoAlert cell
fractionation kit (BD Biosciences, Mississauga, ON, Canada) ac-
cording to the manufacture’s instructions. Enriched mitochondrial
and cytosolic fractions were diluted with 63 Laemmli sample buffer
(0.375 M Tris-HCl [pH 6.8], 12% w/v SDS, 3% v/v glycerol, 0.2% w/v
bromphenol blue, 12% b-mercaptoethanol in double distilled water)
and boiled for 5 min. A total of 25 mg of proteins of each sample were
loaded onto a 15% polyacrylamide gel and were transferred onto
a nitrocellulose membrane (Bio-Rad, Mississauga, ON, Canada). Cy-
tochrome c and cytochrome c oxidase subunit IV (COX-4) antibody
were provided in the ApoAlert kit and were used at dilutions of
1:1000 and 1:500, respectively. Actin antibody (Chemicon, Teme-
cula, CA) was used at a dilution of 1:1000. Secondary antibodies
were purchased from Amersham Biosciences (Baie D’Urfe, QC,
Canada). The specific protein bands were detected by using ECL re-
agent (Amersham Biosciences) and were quantified with the MCID-
M4 imaging system (Imaging Research).
Cytochrome c ELISA
The cytochrome c ELISA kit was purchased from Chemicon. The
concentration of cytochrome c in mitochondrial fractions was deter-
mined according to the manufacturer’s instructions.
Statistical Analysis
Data were analyzed by using SYSTAT 10 (SPSS, Chicago, IL). Statis-
tical significance was determined by a Student’s t test, 1-way
ANOVA followed by multiparametric Dunnett’s post-hoc test, or 2-
way ANOVA. Differences were considered significant in instances
where p < 0.05.
Supplemental Data
Supplemental Data including Figure S1 showing changes in mito-
chondrial morphology upon QD treatments and Figure S2 showing
ROS formation in the presence of QDs, as revealed by enhanced
nuclear staining with ethidium (red), and its reduction by NAC are
available at http://www.chembiol.com/cgi/content/full/12/11/1227/
DC1/.
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